Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. / Styring, Emelie; Fernebro, Josefin; Jönsson, Per-Ebbe; Ehinger, Anna; Engellau, Jacob; Rissler, Pehr; Rydholm, Anders; Nilbert, Mef; Vult von Steyern, Fredrik; Styring, Emelie; Fernebro, Josefin; Jönsson, Per-Ebbe; Ehinger, Anna; Engellau, Jacob; Rissler, Pehr; Rydholm, Anders; Nilbert, Mef; Vult von Steyern, Fredrik.

In: Breast Cancer Research and Treatment, Vol. 122, No. 3, 2010, p. 883-7.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Styring, E, Fernebro, J, Jönsson, P-E, Ehinger, A, Engellau, J, Rissler, P, Rydholm, A, Nilbert, M, Vult von Steyern, F, Styring, E, Fernebro, J, Jönsson, P-E, Ehinger, A, Engellau, J, Rissler, P, Rydholm, A, Nilbert, M & Vult von Steyern, F 2010, 'Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall', Breast Cancer Research and Treatment, vol. 122, no. 3, pp. 883-7. https://doi.org/10.1007/s10549-009-0703-8

APA

Styring, E., Fernebro, J., Jönsson, P-E., Ehinger, A., Engellau, J., Rissler, P., Rydholm, A., Nilbert, M., Vult von Steyern, F., Styring, E., Fernebro, J., Jönsson, P-E., Ehinger, A., Engellau, J., Rissler, P., Rydholm, A., Nilbert, M., & Vult von Steyern, F. (2010). Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Research and Treatment, 122(3), 883-7. https://doi.org/10.1007/s10549-009-0703-8

Vancouver

Styring E, Fernebro J, Jönsson P-E, Ehinger A, Engellau J, Rissler P et al. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Research and Treatment. 2010;122(3):883-7. https://doi.org/10.1007/s10549-009-0703-8

Author

Styring, Emelie ; Fernebro, Josefin ; Jönsson, Per-Ebbe ; Ehinger, Anna ; Engellau, Jacob ; Rissler, Pehr ; Rydholm, Anders ; Nilbert, Mef ; Vult von Steyern, Fredrik ; Styring, Emelie ; Fernebro, Josefin ; Jönsson, Per-Ebbe ; Ehinger, Anna ; Engellau, Jacob ; Rissler, Pehr ; Rydholm, Anders ; Nilbert, Mef ; Vult von Steyern, Fredrik. / Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. In: Breast Cancer Research and Treatment. 2010 ; Vol. 122, No. 3. pp. 883-7.

Bibtex

@article{1e7e10e77e6d47f287cf9da7bcae4aef,
title = "Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall",
abstract = "Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008 in the Southern Swedish health care region. In total, 31 angiosarcomas developed at a median age of 71 years. The patients formed two distinct groups; 14 females treated for breast cancer with radical mastectomy and radiotherapy 1949-1988 developed angiosarcomas in edematous arms (Stewart-Treves syndrome) after median 11 years, and 17 females treated by segmental resection, anti-hormonal treatment and radiotherapy 1980-2005 developed angiosarcomas in the irradiated field on the thoracic wall after median 7.3 years. The clinical presentations were heterogeneous and included hematoma-like lesions, multiple bluish-reddish nodules, and asymptomatic lumps. The overall 5-year survival was 16%. In this population-based cohort, the early angiosarcomas developed in edematous arms after radical mastectomies, whereas more recent cases occurred after a shorter time period in the irradiated fields following breast conserving surgery. We conclude that the clinical presentation of angiosarcomas has changed, parallel with altered treatment principles for breast cancer.",
author = "Emelie Styring and Josefin Fernebro and Per-Ebbe J{\~A}¶nsson and Anna Ehinger and Jacob Engellau and Pehr Rissler and Anders Rydholm and Mef Nilbert and {Vult von Steyern}, Fredrik and Emelie Styring and Josefin Fernebro and Per-Ebbe J{\"o}nsson and Anna Ehinger and Jacob Engellau and Pehr Rissler and Anders Rydholm and Mef Nilbert and {Vult von Steyern}, Fredrik",
year = "2010",
doi = "http://dx.doi.org/10.1007/s10549-009-0703-8",
language = "English",
volume = "122",
pages = "883--7",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall

AU - Styring, Emelie

AU - Fernebro, Josefin

AU - Jönsson, Per-Ebbe

AU - Ehinger, Anna

AU - Engellau, Jacob

AU - Rissler, Pehr

AU - Rydholm, Anders

AU - Nilbert, Mef

AU - Vult von Steyern, Fredrik

AU - Styring, Emelie

AU - Fernebro, Josefin

AU - Jönsson, Per-Ebbe

AU - Ehinger, Anna

AU - Engellau, Jacob

AU - Rissler, Pehr

AU - Rydholm, Anders

AU - Nilbert, Mef

AU - Vult von Steyern, Fredrik

PY - 2010

Y1 - 2010

N2 - Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008 in the Southern Swedish health care region. In total, 31 angiosarcomas developed at a median age of 71 years. The patients formed two distinct groups; 14 females treated for breast cancer with radical mastectomy and radiotherapy 1949-1988 developed angiosarcomas in edematous arms (Stewart-Treves syndrome) after median 11 years, and 17 females treated by segmental resection, anti-hormonal treatment and radiotherapy 1980-2005 developed angiosarcomas in the irradiated field on the thoracic wall after median 7.3 years. The clinical presentations were heterogeneous and included hematoma-like lesions, multiple bluish-reddish nodules, and asymptomatic lumps. The overall 5-year survival was 16%. In this population-based cohort, the early angiosarcomas developed in edematous arms after radical mastectomies, whereas more recent cases occurred after a shorter time period in the irradiated fields following breast conserving surgery. We conclude that the clinical presentation of angiosarcomas has changed, parallel with altered treatment principles for breast cancer.

AB - Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008 in the Southern Swedish health care region. In total, 31 angiosarcomas developed at a median age of 71 years. The patients formed two distinct groups; 14 females treated for breast cancer with radical mastectomy and radiotherapy 1949-1988 developed angiosarcomas in edematous arms (Stewart-Treves syndrome) after median 11 years, and 17 females treated by segmental resection, anti-hormonal treatment and radiotherapy 1980-2005 developed angiosarcomas in the irradiated field on the thoracic wall after median 7.3 years. The clinical presentations were heterogeneous and included hematoma-like lesions, multiple bluish-reddish nodules, and asymptomatic lumps. The overall 5-year survival was 16%. In this population-based cohort, the early angiosarcomas developed in edematous arms after radical mastectomies, whereas more recent cases occurred after a shorter time period in the irradiated fields following breast conserving surgery. We conclude that the clinical presentation of angiosarcomas has changed, parallel with altered treatment principles for breast cancer.

U2 - http://dx.doi.org/10.1007/s10549-009-0703-8

DO - http://dx.doi.org/10.1007/s10549-009-0703-8

M3 - Journal article

VL - 122

SP - 883

EP - 887

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -

ID: 34373248